These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 17492713)

  • 1. Efficient solubilization of inclusion bodies.
    Freydell EJ; Ottens M; Eppink M; van Dedem G; van der Wielen L
    Biotechnol J; 2007 Jun; 2(6):678-84. PubMed ID: 17492713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Techno-economic evaluation of an inclusion body solubilization and recombinant protein refolding process.
    Freydell EJ; van der Wielen LA; Eppink MH; Ottens M
    Biotechnol Prog; 2011; 27(5):1315-28. PubMed ID: 21674819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective expression of the soluble product fraction in Escherichia coli cultures employed in recombinant protein production processes.
    Gnoth S; Simutis R; Lübbert A
    Appl Microbiol Biotechnol; 2010 Aug; 87(6):2047-58. PubMed ID: 20535469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inclusion body anatomy and functioning of chaperone-mediated in vivo inclusion body disassembly during high-level recombinant protein production in Escherichia coli.
    Rinas U; Hoffmann F; Betiku E; Estapé D; Marten S
    J Biotechnol; 2007 Jan; 127(2):244-57. PubMed ID: 16945443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study to develop a single method for retrieving wide class of recombinant proteins from classical inclusion bodies.
    Padhiar AA; Chanda W; Joseph TP; Guo X; Liu M; Sha L; Batool S; Gao Y; Zhang W; Huang M; Zhong M
    Appl Microbiol Biotechnol; 2018 Mar; 102(5):2363-2377. PubMed ID: 29387954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inclusion bodies of fuculose-1-phosphate aldolase as stable and reusable biocatalysts.
    Sans C; García-Fruitós E; Ferraz RM; González-Montalbán N; Rinas U; López-Santín J; Villaverde A; Álvaro G
    Biotechnol Prog; 2012; 28(2):421-7. PubMed ID: 22275283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification and renaturation of recombinant human lymphotoxin (tumour necrosis factor beta) expressed in Escherichia coli as inclusion bodies.
    Jin H; Uddin MS; Huang YL; Teo WK
    J Chem Technol Biotechnol; 1994 Jan; 59(1):67-72. PubMed ID: 7764497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solubilization of Escherichia coli recombinant proteins from inclusion bodies.
    Simpson RJ
    Cold Spring Harb Protoc; 2010 Sep; 2010(9):pdb.prot5485. PubMed ID: 20810632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solubilization and refolding of bacterial inclusion body proteins.
    Singh SM; Panda AK
    J Biosci Bioeng; 2005 Apr; 99(4):303-10. PubMed ID: 16233795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Yield, solubility and conformational quality of soluble proteins are not simultaneously favored in recombinant Escherichia coli.
    Martínez-Alonso M; García-Fruitós E; Villaverde A
    Biotechnol Bioeng; 2008 Dec; 101(6):1353-8. PubMed ID: 18980180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soybean disease resistance protein RHG1-LRR domain expressed, purified and refolded from Escherichia coli inclusion bodies: preparation for a functional analysis.
    Afzal AJ; Lightfoot DA
    Protein Expr Purif; 2007 Jun; 53(2):346-55. PubMed ID: 17287130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cooperation between two ClpB isoforms enhances the recovery of the recombinant β-galactosidase from inclusion bodies.
    Guenther I; Zolkiewski M; Kędzierska-Mieszkowska S
    Biochem Biophys Res Commun; 2012 Oct; 426(4):596-600. PubMed ID: 22982305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A single step method for the solubilization and refolding of recombinant protein from E. coli inclusion bodies.
    Crivelli E; Cardamone M; Puri NK
    Aust J Biotechnol; 1991 Apr; 5(2):78-80, 86. PubMed ID: 1367324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein expression and refolding--a practical guide to getting the most out of inclusion bodies.
    Cabrita LD; Bottomley SP
    Biotechnol Annu Rev; 2004; 10():31-50. PubMed ID: 15504702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production of enzymatically active ketosteroid isomerase following insoluble expression in Escherichia coli.
    Hutchinson MH; Morreale G; Middelberg AP; Chase HA
    Biotechnol Bioeng; 2006 Nov; 95(4):724-33. PubMed ID: 16897731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient solubilization, activation, and purification of recombinant Cry45Aa of Bacillus thuringiensis expressed as inclusion bodies in Escherichia coli.
    Okumura S; Saitoh H; Wasano N; Katayama H; Higuchi K; Mizuki E; Inouye K
    Protein Expr Purif; 2006 May; 47(1):144-51. PubMed ID: 16307894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High pH solubilization and chromatography-based renaturation and purification of recombinant human granulocyte colony-stimulating factor from inclusion bodies.
    Li M; Fan H; Liu J; Wang M; Wang L; Wang C
    Appl Biochem Biotechnol; 2012 Mar; 166(5):1264-74. PubMed ID: 22212394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renaturation, purification and characterization of streptokinase expressed as inclusion body in recombinant E. coli.
    Cherish Babu PV; Srinivas VK; Krishna Mohan V; Krishna E
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jan; 861(2):218-26. PubMed ID: 17981102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renaturation of the catalytic domain of PDE4A expressed in Escherichia coli as inclusion bodies.
    Richter W; Hermsdorf T; Dettmer D
    Methods Mol Biol; 2005; 307():155-65. PubMed ID: 15988062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Refolding of therapeutic proteins produced in Escherichia coli as inclusion bodies.
    Misawa S; Kumagai I
    Biopolymers; 1999; 51(4):297-307. PubMed ID: 10618597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.